Sun Pharmaceutical (SUNPHARMA) — Corporate Action

Sun Pharmaceutical's wholly-owned subsidiaries—Sun Pharmaceutical Medicare Limited, Green Eco Development Centre Limited, Faststone Mercantile Company Private Limited, Realstone Multitrade Private Limited, and Skisen Labs Private Limited—have been approved for amalgamation with the parent company by the NCLT on 7 October 2025. The scheme also includes reclassification of General Reserve to Retained Earnings. This simplifies Sun Pharma's corporate structure by consolidating subsidiary operations into the parent entity.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SUNPHARMA ✨ Ask AI About This

About Sun Pharmaceutical Industries Limited (SUNPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,50,643.09 Cr P/E: 41.3 ROE: 15.1% ROCE: 20.3%

View full SUNPHARMA stock details →

📡 Get AI alerts when SUNPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUNPHARMA — Free

💡 Ask AI about this filing

"How does this corporate action affect Sun Pharmaceutical Industries Limited's outlook?" "What did Sun Pharmaceutical Industries Limited announce on 8 October 2025?" "Is this positive or negative for SUNPHARMA?"

Ask AI Free →

📊 More SUNPHARMA filings

See all SUNPHARMA filings →

🔥 Also filed on 8 October 2025

POWERGRID Power Grid Corporation of India Limited Announcement AXISBANK Axis Bank Limited Financial Results HCLTECH HCL Technologies Limited Financial Results HDFCLIFE HDFC Life Insurance Company Limited Financial Results HEROMOTOCO Hero MotoCorp Limited Corporate Action IRFC Indian Railway Finance Corporation Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUNPHARMA files new disclosures

Track SUNPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.